Treating Depression Benefits Heart Patients

August 13, 2003 - 0:0
WASHINGTON -- Antidepressant drugs could make heart patients less likely to have a heart attack, U.S. researchers said on Monday.

The drugs -- specifically a class of drugs called SSRIs, which includes Zoloft and related drugs -- make the blood less sticky and less likely to clot, they found.

The study, published in the American Heart Association journal ***Circulation***, suggests that doctors should check heart patients for depression and treat it with drugs if appropriate.

It also may suggest that depression drugs might be useful in heart disease in patients without depression -- although the researchers stressed that more study is needed before anyone jumps to that conclusion.

After a heart attack, 20 percent to 25 percent of patients develop major depression, but doctors were afraid to treat it because earlier studies showed antidepressants could worsen heart disease.

But selective serotonin reuptake inhibitor drugs do not carry the same risk. The action that makes them work on brain cells also affects platelets -- the structures in the blood that help form blood clots.

The team at the Duke University Medical Center in North Carolina and at Johns Hopkins University in Baltimore studied 64 men and women diagnosed with major clinical depression while hospitalized for heart disease.

They were all taking drugs to reduce clotting. "This study looked at whether adding sertraline to these standard treatments provided an additional benefit," Reuters quoted Dr. Christopher O'Connor, director of the heart failure program at Duke, assaiydng in a statement.

Sertraline is sold by Pfizer under the brand name Zoloft and is in the same class of drugs as Eli Lilly and Co's Prozac, sold generically as fluoxetine.

Of 16 measurements of blood "stickiness", 12 were better in the patients taking sertraline, compared to only eight of 16 in those who got placebos instead.

"Down the road, the big question is whether sertraline might be a beneficial cardiovascular drug, used not just to treat cardiac patients with major depression but to reduce cardiac risk in those with mild depression or no depression," O'Connor said.